Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Schizophrenia

  Free Subscription


Articles published in Can J Psychiatry

Retrieve available abstracts of 26 articles:
HTML format



Single Articles


    February 2024
  1. L'HEUREUX S, Huot-Lavoie M, Bergeron A, Bergeron C, et al
    Effect of Cannabis Legalization in Canada on the Incidence of Psychosis Consultations in Quebec City's Psychiatric Emergency Services.
    Can J Psychiatry. 2024 Feb 21:7067437241232901. doi: 10.1177/07067437241232901.
    PubMed    


    September 2023
  2. CHEN S, Lee A, Wang W
    A Meta-Research of Randomized Controlled Trials in the Field of Mental Health: Comparing Pharmacological to Non-Pharmacological Interventions from 1955 to 2020.
    Can J Psychiatry. 2023;68:639-648.
    PubMed     Abstract available


    August 2023
  3. CENAT JM, Lashley M, Jarvis GE, Williams MT, et al
    The Burden of Psychosis in Black Communities in Canada: More than a Feeling, a Black Family Experience.
    Can J Psychiatry. 2023 Aug 27:7067437231197263. doi: 10.1177/07067437231197263.
    PubMed    


  4. TIMM MJ, Robertson CL, Zhand N
    Mortality Rate and Causes of Death in a Canadian Tertiary Schizophrenia Program.
    Can J Psychiatry. 2023 Aug 3:7067437231193887. doi: 10.1177/07067437231193887.
    PubMed    


    July 2023
  5. BARKER LC, Zaheer J, Hussain Z, France J, et al
    Experiences of Sexual and Reproductive Health Care Access for Women and Nonbinary People With Early Psychosis: Towards an Integrated Perspective of Service Users and Clinicians.
    Can J Psychiatry. 2023 Jul 14:7067437231187460. doi: 10.1177/07067437231187460.
    PubMed     Abstract available


    June 2023
  6. CENAT JM, Dromer E, Darius WP, Dalexis RD, et al
    Incidence, Racial Disparities and Factors Related to Psychosis among Black Individuals in Canada: A Scoping Review.
    Can J Psychiatry. 2023 Jun 2:7067437231178957. doi: 10.1177/07067437231178957.
    PubMed     Abstract available


    May 2023
  7. BELKACEM A, Lavigne KM, Makowski C, Chakravarty M, et al
    Effects of Anticholinergic Burden on Verbal Memory Performance in First-Episode Psychosis.
    Can J Psychiatry. 2023 May 30:7067437231179161. doi: 10.1177/07067437231179161.
    PubMed     Abstract available


  8. LESAGE A, Courteau J, Vanasse A
    Erratum in Lesage A, Courteau J, Brodeur S, et al. Urbanicity, Schizophrenia and Equitable Specialist Services Allocation. Can J Psychiatry. 2022;67(2):160-161. doi: 10.1177/07067437211040606. Epub 2021 Sep 6. PMID: 34482764; PMCID: PMC8892047.
    Can J Psychiatry. 2023 May 10:7067437231173818. doi: 10.1177/07067437231173818.
    PubMed    


  9. COOKEY J, McGavin J, Crocker CE, Stewart SH, et al
    In Response to "Clinical Characteristics Associated With Early Phase Psychosis and Comorbid Substance Use": Methodological Concerns-Authors' Reply.
    Can J Psychiatry. 2023 May 2:7067437231173211. doi: 10.1177/07067437231173211.
    PubMed    


    April 2023
  10. SICOTTE R, Iyer SN, Lacourse E, Seguin JR, et al
    Heterogeneity in the Course of Suicidal Ideation and its Relation to Suicide Attempts in First-Episode Psychosis: A 5-Year Prospective Study.
    Can J Psychiatry. 2023 Apr 18:7067437231167387. doi: 10.1177/07067437231167387.
    PubMed     Abstract available


    February 2023
  11. VELDHUIZEN S, Behal A, Zawertailo L, Melamed O, et al
    Outcomes Among People With Schizophrenia Participating in General-Population Smoking Cessation Treatment: An Observational Study.
    Can J Psychiatry. 2023 Feb 9:7067437231155693. doi: 10.1177/07067437231155693.
    PubMed     Abstract available


  12. IYER SN, Rangaswamy T, Mustafa S, Pawliuk N, et al
    Context and Expectations Matter: Social, Recreational, and Independent Functioning among Youth with Psychosis in Chennai, India and Montreal, Canada.
    Can J Psychiatry. 2023 Feb 6:7067437231153796. doi: 10.1177/07067437231153796.
    PubMed     Abstract available


    November 2022
  13. STEPHENSON E, Yusuf A, Gronsbell J, Tu K, et al
    Disruptions in Primary Care among People with Schizophrenia in Ontario, Canada, During the COVID-19 Pandemic.
    Can J Psychiatry. 2022 Nov 30:7067437221140384. doi: 10.1177/07067437221140384.
    PubMed     Abstract available


  14. ALTMAN RAE, Tan EJ, Rossell SL
    Factors Impacting Access and Engagement of Cognitive Remediation Therapy for People with Schizophrenia: A Systematic Review.
    Can J Psychiatry. 2022 Nov 29:7067437221129073. doi: 10.1177/07067437221129073.
    PubMed     Abstract available


    September 2022
  15. NGUYEN MT, Sicotte R, Pires De Oliveira Padilha P, Abdel-Baki A, et al
    Community Treatment Orders use Among Persons With a First Episode of Psychosis in Quebec.
    Can J Psychiatry. 2022 Sep 22:7067437221125284. doi: 10.1177/07067437221125284.
    PubMed     Abstract available


  16. WALDRON I, Senger B, Cookey J, Crown M, et al
    Addressing Stigma and Promoting Help-Seeking Among African Nova Scotian Youth Experiencing Psychosis and Other Mental Health Problems.
    Can J Psychiatry. 2022 Sep 13:7067437221125305. doi: 10.1177/07067437221125305.
    PubMed     Abstract available


    March 2022
  17. TARRIDE JE, Blackhouse G, Abdel-Baki A, Latimer E, et al
    Economic Evaluation of Early Psychosis Interventions From A Canadian Perspective.
    Can J Psychiatry. 2022 Mar 21:7067437221087044. doi: 10.1177/07067437221087044.
    PubMed     Abstract available


  18. STEWART AJ, Patten SB, Fiest KM, Williamson TS, et al
    10-Year Trends in Healthcare Spending among Patients with Schizophrenia in Alberta, Canada.
    Can J Psychiatry. 2022 Mar 4:7067437221082885. doi: 10.1177/07067437221082885.
    PubMed     Abstract available


    February 2022
  19. ROTENBERG M, Tuck A, Anderson KK, McKenzie K, et al
    Green Space and the Incidence of Schizophrenia in Toronto, Canada.
    Can J Psychiatry. 2022 Feb 4:7067437221076722. doi: 10.1177/07067437221076722.
    PubMed    


    January 2022
  20. CALLAGHAN RC, Sanches M, Murray RM, Konefal S, et al
    Associations Between Canada's Cannabis Legalization and Emergency Department Presentations for Transient Cannabis-Induced Psychosis and Schizophrenia Conditions: Ontario and Alberta, 2015-2019.
    Can J Psychiatry. 2022 Jan 12:7067437211070650. doi: 10.1177/07067437211070650.
    PubMed     Abstract available


  21. BERTULIES-ESPOSITO B, Iyer S, Abdel-Baki A
    The Impact of Policy Changes, Dedicated Funding and Implementation Support on Early Intervention Programs for Psychosis.
    Can J Psychiatry. 2022 Jan 11:7067437211065726. doi: 10.1177/07067437211065726.
    PubMed     Abstract available


    December 2021
  22. AHLUWALIA A, Rafizadeh R, White RF, Bahji A, et al
    Listening to the Patient's Voice: A Patient-Centred Approach to Treatment-Resistant Schizophrenia.
    Can J Psychiatry. 2021 Dec 10:7067437211066262. doi: 10.1177/07067437211066262.
    PubMed    


  23. FERNANDEZ A, Pasquet-Levy M, Laure G, Thummler S, et al
    [Neurodevelopmental Disorders, Psychiatric Comorbidities and Associated Pathologies in Patients with Childhood-Onset Schizophrenia and Premorbid Autistic Symptoms.]
    Can J Psychiatry. 2021;66:1042-1050.
    PubMed     Abstract available


    September 2021
  24. LESAGE A, Courteau J, Brodeur S, Stip E, et al
    Urbanicity, Schizophrenia and Equitable Specialist Services Allocation.
    Can J Psychiatry. 2021 Sep 6:7067437211040606. doi: 10.1177/07067437211040606.
    PubMed    


    August 2021
  25. VANDEVELDE A, Metivier L, Dollfus S
    Impact cerebral structurel et fonctionnel de la Clozapine chez les patients souffrant de schizophrenie : revue systematique des etudes longitudinales en neuroimagerie.
    Can J Psychiatry. 2021;66:683-700.
    PubMed     Abstract available


    April 2021
  26. LECOMTE T, Addington J, Bowie C, Lepage M, et al
    The Canadian Network for Research in Schizophrenia and Psychoses: A Nationally Focused Approach to Psychosis and Schizophrenia Research.
    Can J Psychiatry. 2021 Apr 19:7067437211009122. doi: 10.1177/07067437211009122.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.